Literature DB >> 10092992

Management of renal cell carcinoma in von Hippel-Lindau disease.

F J Hes1, P J Slootweg, T J van Vroonhoven, R J Hené, M A Feldberg, R A Zewald, J K Ploos van Amstel, J W Höppener, P L Pearson, C J Lips.   

Abstract

BACKGROUND: An evaluation of nephron-sparing surgery (NSS) or radical nephrectomy (RN) for treating renal cell carcinoma (RCC) in patients with von Hippel-Lindau disease (VHL) was carried out.
METHODS: Between 1976 and 1997, 10 patients with RCC from four VHL families, of whom seven were from one family, were studied by clinical and histopathological examination. Before 1991, three patients were treated using RN, and thereafter five patients were treated using NSS. Two patients were not operated on.
RESULTS: RCCs in our patients showed a slow growth rate (on average 0.3 cm year-1), and asymptomatic patients presented with tumours of low-grade malignancy. In all patients, tumours were surrounded by a fibrous pseudocapsule. In 5 out of 17 tumours, pseudocapsular invasion was observed, and three of these five tumours broke through the pseudocapsule. To date, these patients have not shown a less favourable outcome than those without pseudocapsular involvement by tumour growth. Multicentricity of RCC was relatively low (4.6 lesions per kidney). In two of the three RN patients, only a single satellite lesion, in the direct vicinity of a RCC, was found in one kidney. Six tumours (1.8-5.5 cm) were enucleated by NSS. During a mean follow-up of 30 months, renal function in these patients was well preserved.
CONCLUSIONS: In our patients, RCCs grew slowly, were of low grade, had a dense fibrous pseudocapsule and were thus good candidates for NSS.

Entities:  

Mesh:

Year:  1999        PMID: 10092992     DOI: 10.1046/j.1365-2362.1999.00402.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  5 in total

1.  Von hippel-lindau disease.

Authors:  Frederik J Hes; Jo Wm Höppener; Rob B van der Luijt; Cornelis Jm Lips
Journal:  Hered Cancer Clin Pract       Date:  2005-11-15       Impact factor: 2.857

2.  Clinical characteristics of renal cell carcinoma in Korean patients with von Hippel-Lindau disease compared to sporadic bilateral or multifocal renal cell carcinoma.

Authors:  Won Tae Kim; Won Sik Ham; Hee Jeong Ju; Jin Sun Lee; Jin Sung Lee; Young Deuk Choi
Journal:  J Korean Med Sci       Date:  2009-11-09       Impact factor: 2.153

3.  von Hippel-Lindau disease with bilateral multiple renal cell carcinoma managed by right radical nephrectomy and left repeat partial nephrectomy.

Authors:  M S Ansari; N P Gupta; Pawan Kumar
Journal:  Int Urol Nephrol       Date:  2003       Impact factor: 2.370

4.  Fluorodeoxyglucose positron emission tomography-computed tomography scan in von Hippel-Lindau syndrome: A case report and review of literature.

Authors:  Shrikant Solav; Ritu Bhandari
Journal:  Indian J Nucl Med       Date:  2012-04

5.  Growth characteristics and therapeutic decision markers in von Hippel-Lindau disease patients with renal cell carcinoma.

Authors:  Patrick Schuhmacher; Emily Kim; Felix Hahn; Peggy Sekula; Cordula Annette Jilg; Christian Leiber; Hartmut P Neumann; Wolfgang Schultze-Seemann; Gerd Walz; Stefan Zschiedrich
Journal:  Orphanet J Rare Dis       Date:  2019-10-28       Impact factor: 4.123

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.